Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals
Identifieur interne : 002E54 ( Main/Exploration ); précédent : 002E53; suivant : 002E55Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals
Auteurs : Emmanuelle Godefroy [États-Unis] ; Yu Wang [États-Unis] ; Naira E. Souleimanian [États-Unis] ; Luigi Scotto [États-Unis] ; Stefan Stevanovic [Allemagne] ; Yao-Tseng Chen [États-Unis] ; Danila Valmori [États-Unis] ; Maha Ayyoub [États-Unis]Source :
- Cancer Immunology, Immunotherapy [ 0340-7004 ] ; 2007-08-01.
English descriptors
- KwdEn :
Abstract
Abstract: Proteins encoded by genes of the SSX family are specifically expressed in tumors and are therefore relevant targets for cancer immunotherapy. One of the first identified family members, SSX-1, is expressed in a large fraction of synovial sarcomas as a fusion protein together with the product of the SYT gene. In addition, the full-length SSX-1 antigen is frequently expressed in tumors of several other histological types such as sarcoma, melanoma, hepatocellular carcinoma, ovarian cancer and myeloma. To date, however, SSX-1 specific T cell responses have not been investigated and no SSX-1 derived T cell epitopes have been described. Here, we have assessed the presence of CD4+ T cells directed against the SSX-1 antigen in circulating lymphocytes of cancer-free individuals. After a single in vitro stimulation with a pool of peptides spanning the entire SSX-1 protein we could detect and isolate SSX-1-specific CD4+ T cells from 5/5 donors analyzed. SSX-1-specific polyclonal populations isolated from these cultures recognized peptides located in three distinct regions of the protein containing clusters of sequences with significant predicted binding to frequently expressed MHC class II alleles. Characterization of specific clonal CD4+ T cell populations derived from one donor allowed the identification of several naturally processed epitopes recognized in association with HLA-DR. These data document the existence of a significant repertoire of CD4+ T cells specific for SSX-1 derived sequences in circulating lymphocytes of any individual that can be exploited for the development of both passive and active immunotherapeutic approaches to control disease evolution in cancer patients.
Url:
DOI: 10.1007/s00262-006-0269-9
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001947
- to stream Istex, to step Curation: 001947
- to stream Istex, to step Checkpoint: 000A29
- to stream Main, to step Merge: 002E84
- to stream Main, to step Curation: 002E54
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals</title><author><name sortKey="Godefroy, Emmanuelle" sort="Godefroy, Emmanuelle" uniqKey="Godefroy E" first="Emmanuelle" last="Godefroy">Emmanuelle Godefroy</name></author><author><name sortKey="Wang, Yu" sort="Wang, Yu" uniqKey="Wang Y" first="Yu" last="Wang">Yu Wang</name></author><author><name sortKey="Souleimanian, Naira E" sort="Souleimanian, Naira E" uniqKey="Souleimanian N" first="Naira E." last="Souleimanian">Naira E. Souleimanian</name></author><author><name sortKey="Scotto, Luigi" sort="Scotto, Luigi" uniqKey="Scotto L" first="Luigi" last="Scotto">Luigi Scotto</name></author><author><name sortKey="Stevanovic, Stefan" sort="Stevanovic, Stefan" uniqKey="Stevanovic S" first="Stefan" last="Stevanovic">Stefan Stevanovic</name></author><author><name sortKey="Chen, Yao Tseng" sort="Chen, Yao Tseng" uniqKey="Chen Y" first="Yao-Tseng" last="Chen">Yao-Tseng Chen</name></author><author><name sortKey="Valmori, Danila" sort="Valmori, Danila" uniqKey="Valmori D" first="Danila" last="Valmori">Danila Valmori</name></author><author><name sortKey="Ayyoub, Maha" sort="Ayyoub, Maha" uniqKey="Ayyoub M" first="Maha" last="Ayyoub">Maha Ayyoub</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B0568BA38C8422E6894801311B2FF4A8B9CD527A</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1007/s00262-006-0269-9</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-W1JQRHHR-T/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001947</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001947</idno><idno type="wicri:Area/Istex/Curation">001947</idno><idno type="wicri:Area/Istex/Checkpoint">000A29</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A29</idno><idno type="wicri:doubleKey">0340-7004:2006:Godefroy E:assessment:of:cd</idno><idno type="wicri:Area/Main/Merge">002E84</idno><idno type="wicri:Area/Main/Curation">002E54</idno><idno type="wicri:Area/Main/Exploration">002E54</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals</title><author><name sortKey="Godefroy, Emmanuelle" sort="Godefroy, Emmanuelle" uniqKey="Godefroy E" first="Emmanuelle" last="Godefroy">Emmanuelle Godefroy</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-07, 10032, New York, NY</wicri:regionArea><wicri:noRegion>NY</wicri:noRegion></affiliation></author><author><name sortKey="Wang, Yu" sort="Wang, Yu" uniqKey="Wang Y" first="Yu" last="Wang">Yu Wang</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-07, 10032, New York, NY</wicri:regionArea><wicri:noRegion>NY</wicri:noRegion></affiliation></author><author><name sortKey="Souleimanian, Naira E" sort="Souleimanian, Naira E" uniqKey="Souleimanian N" first="Naira E." last="Souleimanian">Naira E. Souleimanian</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-07, 10032, New York, NY</wicri:regionArea><wicri:noRegion>NY</wicri:noRegion></affiliation></author><author><name sortKey="Scotto, Luigi" sort="Scotto, Luigi" uniqKey="Scotto L" first="Luigi" last="Scotto">Luigi Scotto</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-07, 10032, New York, NY</wicri:regionArea><wicri:noRegion>NY</wicri:noRegion></affiliation></author><author><name sortKey="Stevanovic, Stefan" sort="Stevanovic, Stefan" uniqKey="Stevanovic S" first="Stefan" last="Stevanovic">Stefan Stevanovic</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Immunology, Institute for Cell Biology, University of Tubingen, Tubingen</wicri:regionArea><wicri:noRegion>Tubingen</wicri:noRegion><wicri:noRegion>Tubingen</wicri:noRegion></affiliation></author><author><name sortKey="Chen, Yao Tseng" sort="Chen, Yao Tseng" uniqKey="Chen Y" first="Yao-Tseng" last="Chen">Yao-Tseng Chen</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pathology, Weill Medical College of Cornell University, New York, NY</wicri:regionArea><wicri:noRegion>NY</wicri:noRegion></affiliation></author><author><name sortKey="Valmori, Danila" sort="Valmori, Danila" uniqKey="Valmori D" first="Danila" last="Valmori">Danila Valmori</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-07, 10032, New York, NY</wicri:regionArea><wicri:noRegion>NY</wicri:noRegion></affiliation></author><author><name sortKey="Ayyoub, Maha" sort="Ayyoub, Maha" uniqKey="Ayyoub M" first="Maha" last="Ayyoub">Maha Ayyoub</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-07, 10032, New York, NY</wicri:regionArea><wicri:noRegion>NY</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Cancer Immunology, Immunotherapy</title><title level="j" type="abbrev">Cancer Immunol Immunother</title><idno type="ISSN">0340-7004</idno><idno type="eISSN">1432-0851</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2007-08-01">2007-08-01</date><biblScope unit="volume">56</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1183">1183</biblScope><biblScope unit="page" to="1192">1192</biblScope></imprint><idno type="ISSN">0340-7004</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0340-7004</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Human</term><term>T lymphocytes</term><term>Tumor immunity</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Proteins encoded by genes of the SSX family are specifically expressed in tumors and are therefore relevant targets for cancer immunotherapy. One of the first identified family members, SSX-1, is expressed in a large fraction of synovial sarcomas as a fusion protein together with the product of the SYT gene. In addition, the full-length SSX-1 antigen is frequently expressed in tumors of several other histological types such as sarcoma, melanoma, hepatocellular carcinoma, ovarian cancer and myeloma. To date, however, SSX-1 specific T cell responses have not been investigated and no SSX-1 derived T cell epitopes have been described. Here, we have assessed the presence of CD4+ T cells directed against the SSX-1 antigen in circulating lymphocytes of cancer-free individuals. After a single in vitro stimulation with a pool of peptides spanning the entire SSX-1 protein we could detect and isolate SSX-1-specific CD4+ T cells from 5/5 donors analyzed. SSX-1-specific polyclonal populations isolated from these cultures recognized peptides located in three distinct regions of the protein containing clusters of sequences with significant predicted binding to frequently expressed MHC class II alleles. Characterization of specific clonal CD4+ T cell populations derived from one donor allowed the identification of several naturally processed epitopes recognized in association with HLA-DR. These data document the existence of a significant repertoire of CD4+ T cells specific for SSX-1 derived sequences in circulating lymphocytes of any individual that can be exploited for the development of both passive and active immunotherapeutic approaches to control disease evolution in cancer patients.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Godefroy, Emmanuelle" sort="Godefroy, Emmanuelle" uniqKey="Godefroy E" first="Emmanuelle" last="Godefroy">Emmanuelle Godefroy</name></noRegion><name sortKey="Ayyoub, Maha" sort="Ayyoub, Maha" uniqKey="Ayyoub M" first="Maha" last="Ayyoub">Maha Ayyoub</name><name sortKey="Ayyoub, Maha" sort="Ayyoub, Maha" uniqKey="Ayyoub M" first="Maha" last="Ayyoub">Maha Ayyoub</name><name sortKey="Chen, Yao Tseng" sort="Chen, Yao Tseng" uniqKey="Chen Y" first="Yao-Tseng" last="Chen">Yao-Tseng Chen</name><name sortKey="Scotto, Luigi" sort="Scotto, Luigi" uniqKey="Scotto L" first="Luigi" last="Scotto">Luigi Scotto</name><name sortKey="Souleimanian, Naira E" sort="Souleimanian, Naira E" uniqKey="Souleimanian N" first="Naira E." last="Souleimanian">Naira E. Souleimanian</name><name sortKey="Valmori, Danila" sort="Valmori, Danila" uniqKey="Valmori D" first="Danila" last="Valmori">Danila Valmori</name><name sortKey="Wang, Yu" sort="Wang, Yu" uniqKey="Wang Y" first="Yu" last="Wang">Yu Wang</name></country><country name="Allemagne"><noRegion><name sortKey="Stevanovic, Stefan" sort="Stevanovic, Stefan" uniqKey="Stevanovic S" first="Stefan" last="Stevanovic">Stefan Stevanovic</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E54 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002E54 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B0568BA38C8422E6894801311B2FF4A8B9CD527A
|texte= Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals
}}
| This area was generated with Dilib version V0.6.33. |  |